602 



statement of United States Tobacco Company 



Before the 



House Energy and Commerce Committee 



Subcommittee on Health and the Environment 



April 14, 1994 



United States Tobacco Company welcomes this opportunity to 

 address a number of issues, as they relate to smokeless tobacco 

 products, raised at the March 25, 1994 hearing before this 

 Subcommittee concerning the possible jurisdiction of the Food and 

 Drug Administration over the manufacture of tobacco products, and 

 in Chairman Henry Waxman's March 31, 1994 letter inviting United 

 States Tobacco Company to participate in today's hearing. 



Further, United States Tobacco Company will set the record 

 straight with regard to the baseless claims made by Dr. Gregory 

 Connolly on March 25th concerning United States Tobacco Company's 

 marketing practices. 



To provide a context for this discussion, this statement 

 will briefly address the history of smokeless tobacco, and the 

 background of United States Tobacco Company, its products, and 

 the process by which they are manufactured. 



^4 



